Vector Science and Therapeutics Corp. (TSXV:PAIN)

TSXV:PAIN Income Statement

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	FY 2025	FY 2024
Period Ending	Aug 31, 2025	Aug 31, 2024
Cost of Revenue	0.15	-
Gross Profit	-0.15	-
Selling, General & Admin	0.31	-
Operating Expenses	0.31	-
Operating Income	-0.46	-
Currency Exchange Gain (Loss)	-0.01	-
Other Non Operating Income (Expenses)	-0.43	-
Pretax Income	-0.9	-
Net Income	-0.9	-
Net Income to Common	-0.9	-
Net Income Growth	-	-
Shares Outstanding (Basic)	7	-
Shares Outstanding (Diluted)	7	-
Shares Change	-	-
EPS (Basic)	-0.13	-
EPS (Diluted)	-0.13	-
EPS Growth	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024
Period Ending	Aug 31, 2025	Aug 31, 2024
EBIT	-0.46	-

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error